Skip to main content
Premium Trial:

Request an Annual Quote

NIH Awards $600K to Atom Sciences for Biodefense Research

NEW YORK, Feb. 15 (GenomeWeb News) - The National Institutes of Health has awarded $600,000 to Atom Sciences to develop technology to identify probable pathogens in the case of a biological attack or outbreak, the company said today.

 

The two-year grant was awarded by the National Institute of Allergy and Infectious Disease.

 

Initial research will focus on cholera bacteria.

 

A portion of the work will be carried out at the University of Tennessee's microbiology department.

 

Atom Sciences is a DNA diagnostics and hybridization company based in Oak Ridge, Tenn.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more